These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 26867758

  • 1. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
    Khazanie P, Liang L, Curtis LH, Butler J, Eapen ZJ, Heidenreich PA, Bhatt DL, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF.
    Circ Heart Fail; 2016 Feb; 9(2):e002444. PubMed ID: 26867758
    [Abstract] [Full Text] [Related]

  • 2. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
    Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC.
    J Am Heart Assoc; 2013 Aug 21; 2(4):e000214. PubMed ID: 23966379
    [Abstract] [Full Text] [Related]

  • 3. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
    Hernandez AF, Mi X, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Qualls LG, Peterson ED, Fonarow GC, Curtis LH.
    JAMA; 2012 Nov 28; 308(20):2097-107. PubMed ID: 23188026
    [Abstract] [Full Text] [Related]

  • 4. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
    Ziaeian B, Fonarow GC, Heidenreich PA.
    JACC Heart Fail; 2017 Sep 28; 5(9):632-639. PubMed ID: 28711446
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
    Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.
    Clin Ther; 2009 Mar 28; 31(3):632-43. PubMed ID: 19393854
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG, Fonarow GC, Desai AS, Liang L, Matsouaka R, DeVore AD, Smith EE, Heidenreich P, Hernandez AF, Yancy CW, Bhatt DL.
    J Am Heart Assoc; 2017 Feb 11; 6(2):. PubMed ID: 28189999
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
    Thadani U, Jacob RG.
    Drugs Today (Barc); 2008 Dec 11; 44(12):925-37. PubMed ID: 19198701
    [Abstract] [Full Text] [Related]

  • 11. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM.
    J Am Heart Assoc; 2015 Aug 06; 4(8):e002061. PubMed ID: 26251283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
    Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, Feldman AM, McNamara D, Leggett C.
    Am J Cardiol; 2014 Jul 01; 114(1):151-9. PubMed ID: 24846808
    [Abstract] [Full Text] [Related]

  • 15. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y, Wei J, Hira RS, Kalra A, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Deswal A, Turakhia MP, Glusenkamp N, Virani SS.
    Clin Cardiol; 2016 Mar 01; 39(3):145-9. PubMed ID: 26880649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
    Carmody MS, Anderson JR.
    Cardiol Rev; 2007 Mar 01; 15(1):46-53. PubMed ID: 17172884
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure.
    Patel DB, Shah RM, Bhatt DL, Liang L, Schulte PJ, DeVore AD, Hernandez AF, Heidenreich PA, Yancy CW, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2016 Nov 01; 9(6):757-766. PubMed ID: 27780849
    [Abstract] [Full Text] [Related]

  • 20. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M.
    N Engl J Med; 1991 Aug 01; 325(5):303-10. PubMed ID: 2057035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.